Track the 바이오톡스텍 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 바이오톡스텍 has recorded 38 public disclosures. Market capitalisation: €35.8bn. The latest transaction was filed on 12 March 2026 (Other). Among the most active insiders: 강종구. The full history is openly available.
38
Insider Decl.
0
Thresholds
·
28 ops.
Buy Volume
·
1 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,659 of 26,270 companies
43.4
score / 100
Value
66
Quality
21
FCF yld13%
Earn yld3.4%
EV/EBITDA10.2x
ROE·
Gross mgn13%
Net mgn2.5%
Debt/EBITDA6.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.